Aboard transthyretin: From transport to cleavage

IUBMB Life

Volumn 62, Issue 6, 2010, Pages 429-435

  Liz, Márcia A ^a   Mar, Fernando M ^a,b   Franquinho, Filipa ^a,c   Sousa, Mónica M ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c CESPU   (Portugal)

Author keywords

Amyloid peptide; Apolipoprotein A I; Metallothionein 2; Retinol; Thyroxine; Transthyretin

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; APOLIPOPROTEIN A1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEGALIN; MEMBRANE RECEPTOR; METALLOTHIONEIN II; NORADRENALIN; PERLECAN; PREALBUMIN; PROTEINASE; PTERIN; RETINOL; RETINOL BINDING PROTEIN; THYROXINE; XANTHOPHYLL;

AMYLOIDOSIS; CELL TRANSPORT; ENDOCYTOSIS; ENZYME SUBSTRATE; HUMAN; MEMBRANE BIOLOGY; NERVOUS SYSTEM; NONHUMAN; OXIDATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW;

AMYLOID NEUROPATHIES, FAMILIAL; HUMANS; LIGANDS; MUTATION; PREALBUMIN;

EID: 77953605034     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.340     Document Type: Review

References (60)

1. Kabat, E. A., Moore, D. H., and Landow, H. (1942) An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J. Clin. Invest. 21, 571-577.
2. Soprano, D. R., Herbert, J., Soprano, K. J., Schon, E. A., and Goodman, D. S. (1985) Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J. Biol. Chem. 260, 11793-11798.
3. Dickson, P. W., Aldred, A. R., Marley, P. D., Tu, G. F., Howlett, G. J., and Schreiber, G. (1985) High prealbumin and transferrin mRNA levels in the choroid plexus of rat brain. Biochem. Biophys. Res. Commun. 127, 890-895.
4. Woeber, K. A. and Ingbar, S. H. (1968) The contribution of thyroxinebinding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J. Clin. Invest. 47, 1710-1721.
5. Goodman, D. (1987) Retinoids and retinol-binding proteins. Harvey Lect. 81, 111-132.
6. Liz, M. A., Faro, C. J., Saraiva, M. J., and Sousa, M. M. (2004) Transthyretin, a new cryptic protease. J. Biol. Chem. 279, 21431-21438.
7. Liz, M. A. and Sousa, M. M. (2005) Deciphering cryptic proteases. Cell. Mol. Life Sci. 62, 989-1002.
8. Saraiva, M. J. (2001) Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum. Mutat. 17, 493-503.
9. Fleming, C. E., Saraiva, M. J., and Sousa, M. M. (2007) Transthyretin enhances nerve regeneration. J. Neurochem. 103, 831-839.
10. Sousa, J. C., Grandela, C., Fernandez-Ruiz, J., de Miguel, R., de Sousa, L., Magalhaes, A. I., Saraiva, M. J., Sousa, N., and Palha, J. A. (2004) Transthyretin is involved in depression-like behaviour and exploratory activity. J. Neurochem. 88, 1052-1058.
11. Nunes, A. F., Saraiva, M. J., and Sousa, M. M. (2006) Transthyretin knockouts are a new mouse model for increased neuropeptide Y. FASEB J. 20, 166-168.
12. Sousa, J. C., Marques, F., Dias-Ferreira, E., Cerqueira, J. J., Sousa, N., and Palha, J. A. (2007) Transthyretin influences spatial reference memory. Neurobiol. Learn. Mem. 88, 381-385.
13. Bartalena, L. (1990) Recent achievements in studies on thyroid hormone- binding proteins. Endocr. Rev. 11, 47-64.
14. Blake, C. C., Geisow, M. J., Oatley, S. J., Rerat, B., and Rerat, C. (1978) Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J. Mol. Biol. 121, 339-356.
15. Ferguson, R. N., Edelhoch, H., Saroff, H. A., Robbins, J., and Cahnmann, H. J. (1975) Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1- naphthalenesulfonic acid. Biochemistry 14, 282-289.
16. Palha, J. A., Episkopou, V., Maeda, S., Shimada, K., Gottesman, M. E., and Saraiva, M. J. (1994) Thyroid hormone metabolism in a transthyretin- null mouse strain. J. Biol. Chem. 269, 33135-33139.
17. Palha, J. A., Hays, M. T., Morreale de Escobar, G., Episkopou, V., Gottesman, M. E., and Saraiva, M. J. (1997) Transthyretin is not essential for thyroxine to reach the brain and other tissues in transthyretinnull mice. Am. J. Physiol. 272, E485-493.
18. Mendel, C. M. (1989) The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 10, 232-274.
19. Kassem, N. A., Deane, R., Segal, M. B., and Preston, J. E. (2006) Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R1310-R1315.
20. Goodman, D. S. (1984) Vitamin A and retinoids in health and disease. N. Engl. J. Med. 310, 1023-1031.
21. Wolf, G. (1984) Multiple functions of vitamin A. Physiol. Rev. 64, 873-937.
22. Noy, N., Slosberg, E., and Scarlata, S. (1992) Interactions of retinol with binding proteins: studies with retinol-binding protein and with transthyretin. Biochemistry 31, 11118-11124.
23. Naylor, H. M. and Newcomer, M. E. (1999) The structure of human retinol- binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry 38, 2647-2653.
24. Monaco, H. L., Rizzi, M., and Coda, A. (1995) Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 268, 1039-1041.
25. Episkopou, V., Maeda, S., Nishiguchi, S., Shimada, K., Gaitanaris, G. A., Gottesman, M. E., and Robertson, E. J. (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc. Natl. Acad. Sci. USA 90, 2375-2379.
26. van Bennekum, A. M., Wei, S., Gamble, M. V., Vogel, S., Piantedosi, R., Gottesman, M., Episkopou, V., and Blaner, W. S. (2001) Biochemical basis for depressed serum retinol levels in transthyretin-deficient mice. J. Biol. Chem. 276, 1107-1113.
27. Wei, S., Episkopou, V., Piantedosi, R., Maeda, S., Shimada, K., Gottesman, M. E., and Blaner, W. S. (1995) Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J. Biol. Chem. 270, 866-870.
28. Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D., and Sun, H. (2007) A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315, 820-825.
29. Sousa, M. M. and Saraiva, M. J. (2001) Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)- sensitive receptor. J. Biol. Chem. 276, 14420-14425.
30. Divino, C. M. and Schussler, G. C. (1990) Transthyretin receptors on human astrocytoma cells. J. Clin. Endocrinol. Metab. 71, 1265-1268.
31. Kuchler-Bopp, S., Dietrich, J. B., Zaepfel, M., and Delaunoy, J. P. (2000) Receptor-mediated endocytosis of transthyretin by ependymoma cells. Brain Res. 870, 185-194.
32. Vieira, A. V., Sanders, E. J., and Schneider, W. J. (1995) Transport of serum transthyretin into chicken oocytes. A receptor-mediated mechanism. J. Biol. Chem. 270, 2952-2956.
33. Sousa, M. M., Norden, A. G., Jacobsen, C., Willnow, T. E., Christensen, E. I., Thakker, R. V., Verroust, P. J., Moestrup, S. K., and Saraiva, M. J. (2000) Evidence for the role of megalin in renal uptake of transthyretin. J. Biol. Chem. 275, 38176-38181.
34. Lisi, S., Segnani, C., Mattii, L., Botta, R., Marcocci, C., Dolfi, A., McCluskey, R. T., Pinchera, A., Bernardini, N., and Marino, M. (2005) Thyroid dysfunction in megalin deficient mice. Mol. Cell. Endocrinol. 236, 43-47.
35. Fleming, C. E., Mar, F. M., Franquinho, F., Saraiva, M. J., and Sousa, M. M. (2009) Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J. Neurosci. 29, 3220-3232.
36. Sousa, M. M., Yan, S. D., Stern, D., and Saraiva, M. J. (2000) Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab. Invest. 80, 1101-1110.
37. Boomsma, F., Man in 't Veld, A. J., and Schalekamp, M. A. (1991) Not norepinephrine but its oxidation products bind specifically to plasma proteins. J. Pharmacol. Exp. Ther. 259, 551-557.
38. Pettersson, T., Ernstrom, U., Griffiths, W., Sjovall, J., Bergman, T., and Jornvall, H. (1995) Lutein associated with a transthyretin indicates carotenoid derivation and novel multiplicity of transthyretin ligands. FEBS Lett. 365, 23-26.
39. Ernstrom, U., Pettersson, T., and Jornvall, H. (1995) A yellow component associated with human transthyretin has properties like a pterin derivative, 7,8-dihydropterin-6-carboxaldehyde. FEBS Lett. 360, 177-182.
40. Chen, L., Collins, X. H., Tabatabai, L. B., and White, W. S. (2005) Use of a 13C tracer to investigate lutein as a ligand for plasma transthyretin in humans. Lipids 40, 1013-1022.
41. Hermansen, L. F., Bergman, T., Jornvall, H., Husby, G., Ranlov, I., and Sletten, K. (1995) Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy. Eur. J. Biochem. 227, 772-779.
42. Smeland, S., Kolset, S. O., Lyon, M., Norum, K. R., and Blomhoff, R. (1997) Binding of perlecan to transthyretin in vitro. Biochem. J. 326(Part 3), 829-836.
43. Kisilevsky, R., Lyon, A. W., and Young, I. D. (1992) A critical analysis of postulated pathogenetic mechanisms in amyloidogenesis. Crit. Rev. Clin. Lab. Sci. 29, 59-82.
44. Chang, M. H., Hua, C. T., Isaac, E. L., Litjens, T., Hodge, G., Karageorgos, L. E., and Meikle, P. J. (2004) Transthyretin interacts with the lysosome-associated membrane protein (LAMP-1) in circulation. Biochem. J. 382, 481-489.
45. Purkey, H. E., Dorrell, M. I., and Kelly, J. W. (2001) Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma. Proc. Natl. Acad. Sci. USA 98, 5566-5571.
46. Goncalves, I., Quintela, T., Baltazar, G., Almeida, M. R., Saraiva, M. J., and Santos, C. R. (2008) Transthyretin interacts with metallothionein 2. Biochemistry 47, 2244-2251.
47. Fitzgerald, M., Nairn, P., Bartlett, C. A., Chung, R. S., West, A. K., and Beazley, L. D. (2007) Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp. Brain Res. 183, 171-180.
48. Tanaka, Y., Ando, Y., Kumamoto, T., Miyazaki, A., Nakamura, M., Nakayama, M., Araki, S., and Ando, M. (1994) Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) type I. Biochim. Biophys. Acta 1225, 311-316.
49. Sousa, M. M., Berglund, L., and Saraiva, M. J. (2000) Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J. Lipid Res. 41, 58-65.
50. de Sousa, M. M., Vital, C., Ostler, D., Fernandes, R., Pouget-Abadie, J., Carles, D., and Saraiva, M. J. (2000) Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis. Am. J. Pathol. 156, 1911-1917.
51. Liz, M. A., Fleming, C. E., Nunes, A. F., Almeida, M. R., Mar, F. M., Choe, Y., Craik, C. S., Powers, J. C., Bogyo, M., and Sousa, M. M. (2009) Substrate specificity of transthyretin: identification of natural substrates in the nervous system. Biochem. J. 419, 467-474.
52. Liz, M. A., Gomes, C. M., Saraiva, M. J., and Sousa, M. M. (2007) ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J. Lipid Res. 48, 2385-2395.
53. Golabek, A., Marques, M. A., Lalowski, M., and Wisniewski, T. (1995) Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci. Lett. 191, 79-82.
54. Costa, R., Goncalves, A., Saraiva, M. J., and Cardoso, I. (2008) Transthyretin binding to A-beta peptide-impact on A-Beta fibrillogenesis and toxicity. FEBS Lett. 582, 936-942.
55. Costa, R., Ferreira-da-Silva, F., Saraiva, M. J., and Cardoso, I. (2008) Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS One 3, e2899.
56. Serot, J. M., Christmann, D., Dubost, T., and Couturier, M. (1997) Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 63, 506-508.
57. Merched, A., Serot, J. M., Visvikis, S., Aguillon, D., Faure, G., and Siest, G. (1998) Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett. 425, 225-228.
58. Stein, T. D. and Johnson, J. A. (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 22, 7380-7388.
59. Choi, S. H., Leight, S. N., Lee, V. M., Li, T., Wong, P. C., Johnson, J. A., Saraiva, M. J., and Sisodia, S. S. (2007) Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J. Neurosci. 27, 7006-7010.
60. Liu, L. and Murphy, R. M. (2006) Kinetics of inhibition of beta-amyloid aggregation by transthyretin. Biochemistry 45, 15702-15709.